Filed: 2/14/2024ACC: 0001214659-24-002612
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 29 equity positions with a total reported market value of $901.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
29
Positions
$901.70M
Total AUM (reported)
86.47M
Total Shares
Allocation by class
COMM$700.07M77.6%
ADRS$201.63M22.4%
Portfolio Concentration
Top 3$210.87M23.4%
4–10$342.05M37.9%
11–25$333.58M37.0%
Rest$15.20M1.7%
Top 3 weight
23.4%
Top 10 weight
61.3%
Voting Authority Distribution
Total shares with voting rights: 86.47M
Sole
Full voting authority
86.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole29
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings29
Rows:
STRUCTURE THERAPEUTICS INC
SOLEShares2.11M
TypeSH
Market value$85.99M
9.54%
Sole
2.11M
Shared
0.00
None
0.00
INHIBRX,INC
SOLEShares1.75M
TypeSH
Market value$66.51M
7.38%
Sole
1.75M
Shared
0.00
None
0.00
ICOSAVAX INC
SOLEShares3.70M
TypeSH
Market value$58.37M
6.47%
Sole
3.70M
Shared
0.00
None
0.00
AN2 Therapeutics, Inc.
SOLEShares2.68M
TypeSH
Market value$54.88M
6.09%
Sole
2.68M
Shared
0.00
None
0.00
RAYZEBIO, INC.
SOLEShares869.91K
TypeSH
Market value$54.08M
6.00%
Sole
869.91K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares2.20M
TypeSH
Market value$49.81M
5.52%
Sole
2.20M
Shared
0.00
None
0.00
GERON CORP
SOLEShares23.38M
TypeSH
Market value$49.32M
5.47%
Sole
23.38M
Shared
0.00
None
0.00
SAVARA INC.
SOLEShares10M
TypeSH
Market value$47.00M
5.21%
Sole
10M
Shared
0.00
None
0.00
GRACELL BIOTECHNOLOGIES INC.
SOLEShares4.51M
TypeSH
Market value$45.33M
5.03%
Sole
4.51M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares179.92K
TypeSH
Market value$41.63M
4.62%
Sole
179.92K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS, INC
SOLEShares3.40M
TypeSH
Market value$41.59M
4.61%
Sole
3.40M
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares2.10M
TypeSH
Market value$36.56M
4.05%
Sole
2.10M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares3.86M
TypeSH
Market value$33.76M
3.74%
Sole
3.86M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.63M
TypeSH
Market value$33.11M
3.67%
Sole
5.63M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.99M
TypeSH
Market value$27.55M
3.06%
Sole
1.99M
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares1.01M
TypeSH
Market value$26.39M
2.93%
Sole
1.01M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS, INC.
SOLEShares1.14M
TypeSH
Market value$23.14M
2.57%
Sole
1.14M
Shared
0.00
None
0.00
DYNE THERAPEUTICS, INC
SOLEShares1.65M
TypeSH
Market value$21.95M
2.43%
Sole
1.65M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$20.47M
2.27%
Sole
1.42M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.04M
TypeSH
Market value$16.24M
1.80%
Sole
2.04M
Shared
0.00
None
0.00
VISTAGEN THERAPEUTICS INC
SOLEShares2.68M
TypeSH
Market value$13.76M
1.53%
Sole
2.68M
Shared
0.00
None
0.00
Abivax SA
SOLEShares1.10M
TypeSH
Market value$11.77M
1.31%
Sole
1.10M
Shared
0.00
None
0.00
CABALETTA BIO, INC
SOLEShares486.80K
TypeSH
Market value$11.05M
1.23%
Sole
486.80K
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares584.96K
TypeSH
Market value$8.83M
0.98%
Sole
584.96K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares717.65K
TypeSH
Market value$7.41M
0.82%
Sole
717.65K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
STRUCTURE THERAPEUTICS INCSOLE | ADRS | 2.11M | SH | $85.99M 9.54% | 2.11M | 0.00 | 0.00 |
INHIBRX,INCSOLE | COMM | 1.75M | SH | $66.51M 7.38% | 1.75M | 0.00 | 0.00 |
ICOSAVAX INCSOLE | COMM | 3.70M | SH | $58.37M 6.47% | 3.70M | 0.00 | 0.00 |
AN2 Therapeutics, Inc.SOLE | COMM | 2.68M | SH | $54.88M 6.09% | 2.68M | 0.00 | 0.00 |
RAYZEBIO, INC.SOLE | COMM | 869.91K | SH | $54.08M 6.00% | 869.91K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COMM | 2.20M | SH | $49.81M 5.52% | 2.20M | 0.00 | 0.00 |
GERON CORPSOLE | COMM | 23.38M | SH | $49.32M 5.47% | 23.38M | 0.00 | 0.00 |
SAVARA INC.SOLE | COMM | 10M | SH | $47.00M 5.21% | 10M | 0.00 | 0.00 |
GRACELL BIOTECHNOLOGIES INC.SOLE | ADRS | 4.51M | SH | $45.33M 5.03% | 4.51M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COMM | 179.92K | SH | $41.63M 4.62% | 179.92K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS, INCSOLE | COMM | 3.40M | SH | $41.59M 4.61% | 3.40M | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADRS | 2.10M | SH | $36.56M 4.05% | 2.10M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | ADRS | 3.86M | SH | $33.76M 3.74% | 3.86M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 5.63M | SH | $33.11M 3.67% | 5.63M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 1.99M | SH | $27.55M 3.06% | 1.99M | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COMM | 1.01M | SH | $26.39M 2.93% | 1.01M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS, INC.SOLE | COMM | 1.14M | SH | $23.14M 2.57% | 1.14M | 0.00 | 0.00 |
DYNE THERAPEUTICS, INCSOLE | COMM | 1.65M | SH | $21.95M 2.43% | 1.65M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $20.47M 2.27% | 1.42M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | COMM | 2.04M | SH | $16.24M 1.80% | 2.04M | 0.00 | 0.00 |
VISTAGEN THERAPEUTICS INCSOLE | COMM | 2.68M | SH | $13.76M 1.53% | 2.68M | 0.00 | 0.00 |
Abivax SASOLE | COMM | 1.10M | SH | $11.77M 1.31% | 1.10M | 0.00 | 0.00 |
CABALETTA BIO, INCSOLE | COMM | 486.80K | SH | $11.05M 1.23% | 486.80K | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COMM | 584.96K | SH | $8.83M 0.98% | 584.96K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COMM | 717.65K | SH | $7.41M 0.82% | 717.65K | 0.00 | 0.00 |
Page 1 of 2